News|Articles|September 26, 2014
FDA and NIH Win Award for IP Licensing of Meningitis Vaccine
Author(s)Pharmaceutical Technology Editors
Partnership is awarded for licensing of low-cost vaccine for the treatment of bacterial meningitis.
Advertisement
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
What Does TAUKLARIFY's Approval Mean for Alzheimer's Drug Developers?
2
Q&A: Why Is Halo Pharma Expanding Into Sterile Injectables Now?
3
Europe Tried to Ban Generative AI From Critical GMP. The Ban May Not Survive. It Does Not Matter.
4
CPHI Milan Puts Sustainability to Work, Part 2
5